Skip to main content
. 2021 Dec 21;2(12):100471. doi: 10.1016/j.xcrm.2021.100471

Figure 3.

Figure 3

Differential responses to carboplatin treatment between sensitive and resistant cell lines (FDR < 0.05)

(A) Global proteins, (B) phosphosites, (C) ubiquitin sites, and (D) mRNAs. The values depicted by color represent log2 fold change (8 or 24 h and 0 h).